29 results on '"Morella, Ilaria"'
Search Results
2. Gut-muscle-brain axis: Molecular mechanisms in neurodegenerative disorders and potential therapeutic efficacy of probiotic supplementation coupled with exercise
3. Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders
4. Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.
5. Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes.
6. Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2
7. Editorial: Cellular and molecular mechanisms in social and repetitive behaviours: a focus on cortico-striatal circuitry.
8. Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice
9. Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
10. Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l‐Dopa‐induced dyskinesia.
11. Dissecting the autism-associated 16p11.2 locus identifies multiple drivers in brain phenotypes and unveils a new role for the major vault protein
12. Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l ‐Dopa‐induced dyskinesia
13. RGS4 negatively modulates Nociceptin/Orphanin FQ opioid receptor signaling: implication for L-Dopa induced dyskinesia
14. Dopamine D1 and Glutamate Receptors Co-operate With Brain-Derived Neurotrophic Factor (BDNF) and TrkB to Modulate ERK Signaling in Adult Striatal Slices
15. The Extracellular Signal-Regulated Kinase (ERK) Cascade in Neuronal Cell Signaling
16. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations
17. The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice
18. The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice
19. Modulation of ERK1/MAPK3 potentiates ERK nuclear signalling, facilitates neuronal cell survival and improves memory in mouse models of neurodegenerative disorders
20. Pharmacological Inhibition of ERK Signaling Rescues Pathophysiology and Behavioral Phenotype Associated with 16p11.2 Chromosomal Deletion in Mice
21. Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
22. Author response: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
23. Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control
24. STUDYING THE RAS-ERK PATHWAY THROUGH SINGLE-CELL ANALYSIS IN ACUTE STRIATAL SLICES
25. Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family
26. Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia
27. Nociceptin/Orphanin FQ Receptor Agonists Attenuate l-DOPA-Induced Dyskinesias
28. The Extracellular Signal-Regulated Kinase (ERK) Cascade in Neuronal Cell Signaling.
29. Noonan syndrome associated with both a new Jnkactivating familial SOS1and a de novo RAF1mutationsMauro Longoni and Silvia Moncini contributed equally to this work.How to Cite this Article: Longoni M, Moncini S, Cisternino M, Morella IM, Ferraiuolo S, Russo S, Mannarino S, Brazzelli V, Coi P, Zippel R, Venturin M, Riva P. 2010. Noonan syndrome associated with both a new Jnkactivating familial SOS1and a de novo RAF1mutations. Am J Med Genet Part A 152A:2176–2184.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.